Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á., Nagy, F., Borman, A., Majoros, L., Kovács, R.: Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. [Epub ahead of print]2024.

Domán, M., Kaszab, E., Laczkó, L., Bali, K., Makrai, L., Kovács, R., Majoros, L., Bányai, K.: Genomic epidemiology of antifungal resistance in human and avian isolates of Candida albicans: a pilot study from the One Health perspective.
Front. Vet. Sci. 11 1-7, 2024.

Jakab, Á., Csillag, K., Antal, K., Boczonádi, I., Kovács, R., Pócsi, I., Emri, T.: Total transcriptome response for tyrosol exposure in Aspergillus nidulans.
Fungal Biol. 128 (2), 1664-1674, 2024.

Kovács, R., Mahmoudi, S.: Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi.
Front. Cell. Infect. Microbiol. 13 1-2, 2023.

Skopkó, B., Paholcsek, M., Szilágyi-Rácz, A., Fauszt, P., Dávid, P., Stündl, L., Váradi, J., Kovács, R., Bágyi, K., Gálné Remenyik, J.: High-Throughput Sequencing Analysis of the Changes in the Salivary Microbiota of Hungarian Young and Adult Subpopulation by an Anthocyanin Chewing Gum and Toothbrush Change.
Dentistry Journal. 11 (2), 1-16, 2023.

Kovács, F., Balla, N., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: Impact of n-acyl-homoserine lactone, quorum sensing molecule, on candida auris isolates.
Acta Microbiol. Immunol. Hung. 70 (Supplement), 30-31, 2023.

Adnan, A., Borman, A., Tóth, Z., Forgács, L., Kovács, R., Balázsi, D., Balázs, B., Udvarhelyi, G., Kardos, G., Majoros, L.: In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades.
Pharmaceutics. 15 (5), 1-16, 2023.

Balla, N., Kovács, F., Tóth, Z., Jakab, Á., Majoros, L., Kovács, R.: The effect of caspofungin in combination with posaconazole against echinocandin susceptible and resistant candida auris isolates.
Acta Microbiol. Immunol. Hung. 70 (Supplement), 6-7, 2023.

Tóth, Z., Bozó, A., Kovács, R., Balogh, B., Balázs, B., Forgács, L., Kelentey, B., Majoros, L.: The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms.
Mycopathologia. 188 (1-2), 111-118, 2023.

Balla, N., Jakab, Á., Kovács, F., Ragyák, Á., Tóth, Z., Balázsi, D., Forgács, L., Bozó, A., Al Refai, F., Borman, A., Majoros, L., Kovács, R.: Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol.
AMB Express. 13 (1), 1-10, 2023.

Kovács, R., Kovács, F., Balla, N., Ragyák, Á., Sajtos, Z., Majoros, L., Jakab, Á.: Transcriptional changes and related physiological effect caused by tyrosol exposure in Candida auris.
In: ECFG16 abstractbook, PCO Tyrol Congress, Innsbruck, 425-426, 2023.

Kovács, R., Majoros, L., Stemler, J., Cornely, O., Salmanton-García, J.: Unveiling the Hungarian landscape of laboratory and clinical management capacities for invasive fungal infections: navigating the frontlines against fungal menaces.
Therapeutic Advances in Infection. [Epub ahead of print]2023.

Kovács, R., Majoros, L.: Antifungal lock therapy: an eternal promise or an effective alternative therapeutic approach?.
Lett. Appl. Microbiol. 74 (6), 851-862, 2022.

Bakó, J., Tóth, F., Gáll, J., Kovács, R., Csik, A., Varga, I., Sculean, A., Zelkó, R., Hegedűs, C.: Combined Release of Antiseptic and Antibiotic Drugs from Visible Light Polymerized Biodegradable Nanocomposite Hydrogels for Periodontitis Treatment.
Pharmaceutics. 14 (5), 1-19, 2022.

Kovács, R., Erdélyi, L., Fenyvesi, F., Balla, N., Kovács, F., Vámosi, G., Klusóczki, Á., Gyöngyösi, A., Bácskay, I., Vecsernyés, M., Váradi, J.: Concentration-Dependent Antibacterial Activity of Chitosan on Lactobacillus plantarum.
Pharmaceutics. 15 (1), 1-11, 2022.

Spengler, G., Gajdács, M., Donadu, M., Usai, M., Marchetti, M., Ferrari, M., Mazzarello, V., Zanetti, S., Nagy, F., Kovács, R.: Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts.
Microorganisms. 10 (4), 1-20, 2022.

Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pfliegler, V., Pócsi, I.: Heme Oxygenase-1 (HMX1) Loss of Function Increases the In-Host Fitness of the Saccharomyces 'boulardii' Probiotic Yeast in a Mouse Fungemia Model.
J. Fungi. 8 (5), 522, 2022.

Erdélyi, L., Fenyvesi, F., Gál, B., Haimhoffer, Á., Vasvári, G., Budai, I., Gálné Remenyik, J., Bereczki, I., Fehér, P., Ujhelyi, Z., Bácskay, I., Vecsernyés, M., Kovács, R., Váradi, J.: Investigation of the Role and Effectiveness of Chitosan Coating on Probiotic Microcapsules.
Polymers. 14 (9), 1-16, 2022.

Forgács, L., Borman, A., Kovács, R., Balázsi, D., Tóth, Z., Balázs, B., Chun-Ju, C., Kardos, G., Kovács, I., Majoros, L.: In Vivo Efficacy of Amphotericin B against Four Candida auris Clades.
J. Fungi. 8 (5), 1-16, 2022.

Katona, M., Jeles, K., Kovács, R., Csoma, E.: KI and WU Polyomaviruses: seroprevalence Study and DNA Prevalence in SARS-CoV-2 RNA Positive and Negative Respiratory Samples.
Microorganisms. 10 (4), 1-12, 2022.

Kovács, R.: Novel strategies for combating fungal biofilms in catheter-associated infections.
Microbiologist magazine June 16-18, 2022.

Jakab, Á., Kovács, F., Balla, N., Tóth, Z., Ragyák, Á., Sajtos, Z., Csillag, K., Nagy-Köteles, C., Nemes, D., Bácskay, I., Pócsi, I., Majoros, L., Kovács, Á., Kovács, R.: Physiological and transcriptional profiling of surfactin exerted antifungal effect against Candida albicans.
Biomed. Pharmacother. 152 1-10, 2022.

Kovács, R.: Special Issue: alternative Therapeutic Approaches of Candida Infections.
J. Fungi. 8 (2), 1-2, 2022.

Balla, N., Kovács, F., Balázs, B., Borman, A., Bozó, A., Jakab, Á., Tóth, Z., Kobaissi, O., Majoros, L., Kovács, R.: Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms.
Antibiotics-Basel. 11 (11), 1-12, 2022.

Kovács, R., Balla, N., Kovács, F., Majoros, L., Jakab, Á.: Transcriptional response of Candida auris biofilms to farnesol and tyrosol treatment.
In: Eurobiofilms abstractbook, [s.n.], Palma de Mallorca, 143, 2022.

Imre, A., Kovács, R., Tóth, Z., Majoros, L., Benkő, Z., Pócsi, I., Pfliegler, V.: Variability of the probiotic yeast saccharomyces cerevisiae var. `BOULARDII` in genome, phenotype, and virulence.
In: Biotechnology at the University of Debrecen - 2022 International Symposium : Abstarct Book, Faculty of Science and Technology, Department of Molecular Biotechnology and Microbiology, Institute of Biotechnology and Faculty of Agricultural and Food Sciences and Environmental Management, Central Laboratory of Agricultural and Food Products, Debrecen, 38-39, 2022. ISBN: 9789634904687

Kovács, R., Tóth, Z., Locke, J., Forgács, L., Kardos, G., Nagy, F., Borman, A., Majoros, L.: Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, 2021.

Nagy, F., Tóth, Z., Váradi, G., Tóth, L., Forgács, L., Vadászi, K., Majoros, L., Galgóczy, L., Kovács, R.: Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68 28-29, 2021.

Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A., Majoros, L., Kovács, R.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.

Arany, P., Papp, I., Bodroginé Zichar, M., Regdon, G., Béres, M., Szalóki, M., Kovács, R., Fehér, P., Ujhelyi, Z., Vecsernyés, M., Bácskay, I.: Manufacturing and Examination of Vaginal Drug Delivery System by FDM 3D Printing.
Pharmaceutics. 13 (10), 1-20, 2021.

Gorliczay, E., Boczonádi, I., Kiss, N., Tóth, F., Pabar, S., Biró, B., Kovács, R., Tamás, J.: Microbiological Effectivity Evaluation of New Poultry Farming Organic Waste Recycling.
Agriculture. 11 (7), 1-21, 2021.

Domán, M., Makrai, L., Lengyel, G., Kovács, R., Majoros, L., Bányai, K.: Molecular Diversity and Genetic Relatedness of Candida albicans Isolates from Birds in Hungary.
Mycopathologia. 186 (2), 237-244, 2021.

Jakab, Á., Emri, T., Csillag, K., Szabó, A., Nagy, F., Baranyai, E., Sajtos, Z., Géczi, D., Antal, K., Kovács, R., Szabó, K., Dombrádi, V., Pócsi, I.: The negative effect of protein phosphatase Z1 deletion on the oxidative stress tolerance of Candida albicans is synergistic with betamethasone exposure.
J. Fungi. 7 (540), 1-24, 2021.

Kovács, R., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G., Vadászi, K., Borman, A., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, 2021.

Balázs, B., Tóth, Z., Nagy, F., Kovács, R., Tóth, H., Nagy, J., Tóth, Á., Szarka, K., Majoros, L., Kardos, G.: The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, 2021.

Jakab, Á., Balla, N., Ragyák, Á., Nagy, F., Kovács, F., Sajtos, Z., Tóth, Z., Borman, A., Pócsi, I., Baranyai, E., Majoros, L., Kovács, R.: Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, 2021.

Kovács, R., Jakab, Á., Ragyák, Á., Sajtos, Z., Nagy, F., Baranyai, E., Pócsi, I., Majoros, L.: Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68 85, 2021.

Papp, Z., Borman, A., Forgács, L., Kovács, R., Tóth, Z., Chun-Ju, C., Kardos, G., Juhász, B., Szilvássy, J., Majoros, L.: Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades.
Pathogens. 10 (8), 1-11, 2021.

Imre, A., Kovács, R., Pázmándi, K., Nemes, D., Jakab, Á., Fekete, T., Rácz, H., Dóczi, I., Bácskay, I., Gácser, A., Kovács, K., Majoros, L., Farkas, Z., Pócsi, I., Pfliegler, V.: Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces 'boulardii').
J. Fungi. 7 (9), 1-29, 2021.

Arany, P., Papp, I., Bodroginé Zichar, M., Budai, I., Béres, M., Regdon, G., Kovács, R., Coleman, A., Perret, F., Mollet, L., Zelkó, R., Kazsoki, A., Elek, J., Csontos, M., Vecsernyés, M., Bácskay, I.: 3D nyomtatóval előállított implantátumok anyagszerkezeti és biokompatibilitási vizsgálatai.
In: III. Fiatal Technológusok Fóruma / Benkő Ernő, ifj. Regdon Géza, Magyar Gyógyszerésztudományi Társaság; Szegedi Tudományegyetem, Szeged, 8, 2020.

Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.

Nemes, D., Kovács, R., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, V., Rebenku, I., Hajdu, P., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143 1-9, 2020.

Forgács, L., Borman, A., Prépost, E., Tóth, Z., Kardos, G., Kovács, R., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.

Kovács, R., Majoros, L.: Fungal Quorum-Sensing Molecules: a Review of Their Antifungal Effect against Candida Biofilms.
J. Fungi. 6 (3), 99, 2020.

Nagy, F., Vitális, E., Jakab, Á., Borman, A., Forgács, L., Tóth, Z., Majoros, L., Kovács, R.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11 1-12, 2020.

Tóth, Z., Forgács, L., Kardos, T., Kovács, R., Locke, J., Kardos, G., Nagy, F., Borman, A., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.

Imre, A., Rácz, H., Antunovics, Z., Rádai, Z., Kovács, R., Lopandic, K., Pócsi, I., Pfliegler, V.: A new, rapid multiplex PCR method identifies frequent probiotic origin among clinical Saccharomyces isolates.
Microbiol. Res. 227 1-7, 2019.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Borman, A., Majoros, L.: Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.

Devi, S., Kiesewalter, H., Kovács, R., Frisvad, J., Weber, T., Larsen, T., Kovács, Á., Ding, L.: Depiction of secondary metabolites and antifungal activity of Bacillus velezensis DTU001.
Synth. Systems Biotechnol. 4 (3), 142-149, 2019.

Prépost, E., Tóth, Z., Perlin, D., Gesztelyi, R., Kardos, G., Kovács, R., Nagy, F., Forgács, L., Majoros, L.: Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12 1805-1814, 2019.

Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A., Majoros, L., Kovács, R.: Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.

Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.

Forgács, L., Tóth, Z., Locke, J., Nagy, F., Balázs, B., Prépost, E., Kardos, G., Kovács, R., Székely, A., Borman, A., Majoros, L.: Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.

Arany, P., Róka, E., Mollet, L., Coleman, A., Perret, F., Kim, B., Kovács, R., Kazsoki, A., Zelkó, R., Gesztelyi, R., Ujhelyi, Z., Fehér, P., Váradi, J., Fenyvesi, F., Vecsernyés, M., Bácskay, I.: Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties.
Pharmaceutics. 11 (6), 1-23, 2019.

Tóth, Z., Forgács, L., Locke, J., Kardos, G., Nagy, F., Kovács, R., Székely, A., Borman, A., Majoros, L.: In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.

Kovács, R., Holzknecht, J., Hargitai, Z., Papp, C., Farkas, A., Borics, A., Tóth, L., Váradi, G., Tóth, G., Kovács, I., Dubrac, S., Majoros, L., Marx, F., Galgóczy, L.: In vivo applicability of Neosartorya fischeri antifungal protein 2 (NFAP2) in treatment of vulvovaginal candidiasis.
Antimicrob. Agents Chemother. 63 (2), 1-12, 2019.

Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., Kovács, R.: Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.: Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.

Nagy, F., Tóth, Z., Forgács, L., Borman, A., Majoros, L., Balázs, B., Kovács, R.: The effect of farnesol on Candida auris biofilms, virulence and azole susceptibility.
J. Fungi. 95 (5), 141-142, 2019.

Kovács, R., Nagy, F., Tóth, Z., Majoros, L.: The effect of nikkomycin Z in combination with echinocandins against Candida albicans and Candida parapsilosis biofilms.
Acta Microbiol. Immunol. Hung. 66 56-57, 2019.

Kovács, R., Jakab, Á., Tóth, Z., Nagy, F., Emri, T., Pócsi, I., Majoros, L.: Transcriptional and physiological effect exerted by tyrosol on Candida parapsilosis cells.
J. Fungi. 5 (95), 142-143, 2019.

Tóth, Z., Kardos, T., Kovács, R., Kardos, G., Nagy, F., Prépost, E., Barta, Z., Takács, I., Majoros, L.: Comparison of Killing Activity of Micafungin Against Six Candida Species Isolated from Peritoneal and Pleural Cavities in RPMI-1640, 10 and 30% Serum.
Mycopathologia. 183 (6), 905-912, 2018.

Nemes, D., Kovács, R., Nagy, F., Mező, M., Poczok, N., Ujhelyi, Z., Pető, Á., Fehér, P., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms: assessment of Cytotoxicity and Antimicrobial Activity.
Molecules. 23 (7), 1-19, 2018.

Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Majoros, L., Kovács, R.: In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates.
Med. Mycol. 56 (4), 493-500, 2018.

Kardos, T., Kovács, R., Kardos, G., Varga, I., Bozó, A., Tóth, Z., Nagy, F., Majoros, L.: Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results.
J. Chemother. 30 (4), 233-239, 2018.

Kovács, R., Nagy, F., Tóth, Z., Bozó, A., Majoros, L.: The effect of human serum on the efficacy of traditional antifungals against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 56 S131, 2018.

Jakab, Á., Nagy, F., Tóth, Z., Nemes, D., Majoros, L., Bácskay, I., Pócsi, I., Kovács, R.: Tyrosol influences the physiology and virulence of Candida parapsilosis.
In: Fiatal Biotechnológusok Országos Konferenciája. Szerk.: Tamás László, Zelenyánszki Helga, JATEPress, Szeged, 95, 2018. ISBN: 9789633153703

Kovács, R., Tóth, Z., Nagy, F., Daróczi, L., Bozó, A., Majoros, L.: Activity of exogenous tyrosol in combination with caspofungin and micafungin against Candida parapsilosis sessile cells.
J. Appl. Microbiol. 122 (6), 1529-1536, 2017.

Boros, E., Pfliegler, V., Kovács, R., Jakab, Á., Majoros, L., Barta, Z., Pócsi, I.: Candida albicans isolates from a single hospital show low phenotypical specialization.
J. Basic Microbiol. 57 (11), 910-921, 2017.

Pfliegler, V., Boros, E., Pázmándi, K., Jakab, Á., Zsuga, I., Kovács, R., Urbán, E., Antunovics, Z., Bácsi, A., Sipiczki, M., Majoros, L., Pócsi, I.: Commercial strain-derived clinical Saccharomyces cerevisiae can evolve new phenotypes without higher pathogenicity.
Mol. Nutr. Food Res. 61 (11), 1601099-1 - 1601099-8, 2017.

Saleh, Q., Kovács, R., Kardos, G., Gesztelyi, R., Kardos, T., Bozó, A., Majoros, L.: Decreased Killing Activity of Micafungin Against Candida guilliermondii, Candida lusitaniae, and Candida kefyr in the Presence of Human Serum.
Microb. Drug Resist. 23 (6), 764-770, 2017.

Kovács, R., Saleh, Q., Bozó, A., Tóth, Z., Gesztelyi, R., Kardos, T., Kardos, G., Takács, I., Majoros, L.: Killing Activity of Micafungin Against Candida albicans, C. dubliniensis and Candida africana in the Presence of Human Serum.
Mycopathologia. 182 (11-12), 979-987, 2017.

Kardos, T., Saleh, Q., Kovács, R., Gesztelyi, R., Kardos, G., Bozó, A., Tóth, Z., Majoros, L.: Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
New Microbiol. 40 (4), 286-288, 2017.

Kovács, R., Nagy, F., Bozó, A., Tóth, Z., Daróczi, L., Kardos, G., Majoros, L.: The in vitro susceptibility pattern of C. kefyr planktonic cells and biofilms against traditional antifungal agents.
Acta Microbiol. Immunol. Hung. 62 152, 2017.

Kovács, R., Bozó, A., Gesztelyi, R., Domán, M., Kardos, G., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Int. J. Antimicrob. Agents. 47 (4), 304-310, 2016.

Domán, M., Kovács, R., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Kardos, T., Saleh, Q., Majoros, L.: Killing rates of caspofungin in 50 percent serum correlate with caspofungin efficacy against Candida albicans in a neutropenic murine model.
Current Drug Del. 13 (2), 255-264, 2016.

Bozó, A., Domán, M., Majoros, L., Kardos, G., Varga, I., Kovács, R.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
J. Microbiol. 54 (11), 753-760, 2016.

Kovács, R., Bozó, A., Nagy, F., Tóth, Z., Majoros, L.: The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Acta Microbiol. Immunol. Hung. 64 16, 2016.

Jakab, Á., Emri, T., Sipos, L., Kiss, Á., Kovács, R., Dombrádi, V., Kemény-Beke, Á., Balla, J., Majoros, L., Pócsi, I.: Betamethasone augments the antifungal effect of menadione-towards a novel anti-combination therapy.
J. Basic Microbiol. 55 (8), 973-981, 2015.

Domán, M., Kovács, R., Perlin, D., Kardos, G., Gesztelyi, R., Juhász, B., Bozó, A., Majoros, L.: Dose escalation studies with caspofungin against Candida glabrata.
J. Med. Microbiol. 64 (9), 998-1007, 2015.

Kovács, R., Bozó, A., Domán, M., Nagy, F., Tóth, Z., Majoros, L.: Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms.
Mycoses. 58 79-80, 2015.

Berényi, R., Kovács, R., Domán, M., Gesztelyi, R., Kardos, G., Juhász, B., Perlin, D., Majoros, L.: Efficacy of single large doses of caspofungin in a neutropenic murine model against the "psilosis" group.
New Microbiol. 37 (3), 355-362, 2014.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua.
J. Med. Microbiol. 63 (2), 186-194, 2014.

Kovács, R., Gesztelyi, R., Perlin, D., Kardos, G., Domán, M., Berényi, R., Majoros, L.: Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
Mycopathologia. 178 (3-4), 197-206, 2014.

Kovács, R., Czudar, A., Horváth, L., Szakács, L., Majoros, L., Kónya, J.: Serum interleukin-6 levels in murine models of Candida albicans infection.
Acta Microbiol. Immunol. Hung. 61 (1), 61-69, 2014.

Majoros, L., Kovács, R., Berényi, R., Domán, M., Miszti, C., Kardos, G.: Effect of 50% human serum on he killing activity of micafungin against C. dubliniensis, C. lusitaniae, C. guilliermondii and C. kefyr using time-kill methodology.
Mycoses. 56 64-65, 2013.

Kovács, R., Gesztelyi, R., Berényi, R., Domán, M., Kardos, G., Juhász, B., Majoros, L.: Should echinocandin doses be increased against Candida species? An in vitro and in vivo study of caspofungin against Candida albicans, C. krusei and C. inconspicua.
Mycoses. 56 (Suppl.), 60, 2013.

Földi, R., Kovács, R., Gesztelyi, R., Kardos, G., Berényi, R., Juhász, B., Szilágyi, J., Mózes, J., Majoros, L.: Comparison of In Vitro and Vivo Efficacy of Caspofungin Against Candida parapsilosis, C. orthopsilosis, C. metapsilosis and C. albicans.
Mycopathologia. 174 (4), 311-318, 2012.

Földi, R., Szilágyi, J., Kardos, G., Berényi, R., Kovács, R., Majoros, L.: Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
Diagn. Microbiol. Infect. Dis. 73 (4), 338-342, 2012.

Bayegan, S., Majoros, L., Kardos, G., Kemény-Beke, Á., Miszti, C., Kovács, R., Gesztelyi, R.: In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin.
J. Microbiol. 48 (2), 170-173, 2010.